Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Peer Review reports

Original Submission
27 Oct 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
12 Dec 2021	Reviewed	Reviewer Report - Yoshihiro Kakeji
23 Dec 2021	Reviewed	Reviewer Report
27 Dec 2021	Reviewed	Reviewer Report - Hiroyuki Uetake
24 Jan 2022	Author responded	Author comments - Qun Zhao
Resubmission - Version 4
24 Jan 2022	Submitted	Manuscript version 4
21 Feb 2022	Author responded	Author comments - Qun Zhao
Resubmission - Version 5
21 Feb 2022	Submitted	Manuscript version 5
Publishing
3 Mar 2022	Editorially accepted
14 Mar 2022	Article published	10.1186/s12876-022-02199-9

Back to article page